相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis (vol 9, 759, 2018)
Fabricio A. Pamplona et al.
FRONTIERS IN NEUROLOGY (2019)
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
W. Haeuser et al.
EUROPEAN JOURNAL OF PAIN (2018)
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study
Moran Hausman-Kedem et al.
BRAIN & DEVELOPMENT (2018)
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center
Giulia S. Porcari et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia
David Neubauer et al.
EPILEPSY & BEHAVIOR (2018)
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
Orrin Devinsky et al.
EPILEPSY & BEHAVIOR (2018)
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders
Stephanie Libzon et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa
Malcolm P. Chelliah et al.
PEDIATRIC DERMATOLOGY (2018)
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience
Kerrie-Anne Chen et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review
Samantha Polito et al.
PEDIATRIC BLOOD & CANCER (2018)
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
A. Suraev et al.
SCIENTIFIC REPORTS (2018)
A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
Blathnaid McCoy et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients
Lauren Treat et al.
EPILEPSIA (2017)
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
Jacqueline S. Gofshteyn et al.
JOURNAL OF CHILD NEUROLOGY (2017)
Interactions between cannabidiol and commonly used antiepileptic drugs
Tyler E. Gaston et al.
EPILEPSIA (2017)
Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
Evan C. Rosenberg et al.
EPILEPSIA (2017)
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use
Anastasia S. Suraev et al.
EPILEPSY & BEHAVIOR (2017)
The current status of artisanal cannabis for the treatment of epilepsy in the United States
Dustin Sulak et al.
EPILEPSY & BEHAVIOR (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
Emma H. Kaplan et al.
PEDIATRIC NEUROLOGY (2017)
Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine
Elisa J. Sobo
SOCIAL SCIENCE & MEDICINE (2017)
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy
Carlos G. Aguirre-Velazquez
NEUROLOGY RESEARCH INTERNATIONAL (2017)
The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms A Systematic Review
Shannon M. Nugent et al.
ANNALS OF INTERNAL MEDICINE (2017)
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting
Joseph V. Pergolizzi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Hypotension associated with ingestion of cannabinoids in two children with cancer
Amanda M. Li et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
Evan J. Hess et al.
EPILEPSIA (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
Jose A. S. Crippa et al.
FRONTIERS IN PHARMACOLOGY (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
Shaun A. Hussain et al.
EPILEPSY & BEHAVIOR (2015)
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
Craig A. Press et al.
EPILEPSY & BEHAVIOR (2015)
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Brenda E. Porter et al.
EPILEPSY & BEHAVIOR (2013)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
分享论文
